The use of perioperative GLP-1 RA reduces the risk of complications in diabetic patients

(Health Day News)-In the case of diabetes patients who have undergone surgical treatment, the active percherative peptide-1 receptor agonist (GLP-1 RA) prescription is re-hospitalized after the risk adjustment, wound detachment, and It is associated with reduced hematoma. Research released online Elderly of surgery。

New York City Seth Aschen and colleagues from Wil Cornel Medicine, and their colleagues examined the surgical complications of diabetics and postoperative hospitalization. 。 It contained patients with type 1 or type 2 diabetes, which had undergone surgical treatment between February 2020 and July 2023.

As a whole, 27.2 % of the 74,425 surgical treatments in 21,772 patients included in the analysis were implemented in the setting of the active GLP-1 RA prescription. The tendency score matched a total of 35,020 procedures for 13,129 patients. Researchers have found that the active GLP-1 RA prescriptions have significantly lower the risk of after 30 days after aggressive, 180 days of surgery, and postoperative hematoma. , 0.883, 0.711, and 0.440). There was no significant difference between infection and bleeding rate.

“It is important to understand the effects on postoperative complications, as the rapid increase in the use of GLP-1 RA in patients, regardless of whether there is a diagnosis of diabetes,” is important to understand the impact on postoperative complications, “he wrote. I am.